Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human genetics implicates a BACH2-NRF2 axis in fetal haemoglobin activation. | Nature | 2026 | 42816612 | PubTator, text mining | PubMed |
| Clinical translation of CRISPR-Cas9 therapeutics in cancer and inherited genetic disorders. | Front Genome Ed | 2026 | 42787623 | PubTator, text mining | PubMed |
| CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia. | Hemoglobin | 2026 | 42755327 | PubTator, text mining | PubMed |
| SaCas9 and AsCas12a Ultra Enable Highly Efficient and Specific Gene Editing in Hematopoietic Stem and Progenitor Cells. | Cell Biomater | 2026 | 42746631 | PubTator, text mining | PubMed |
| A transcription factor-focused CRISPR screen identifies SKI as a BCL11A-independent repressor of ζ-globin. | J Genet Genomics | 2026 | 42710656 | PubTator, text mining | PubMed |
| Molecular genetics analysis of genes BCL11A, HBS1L-MYB, and HBG2 variants association in thalassemic children. | Per Med | 2026 | 42708502 | PubTator, text mining | PubMed |
| Global genetic modifiers of fetal hemoglobin in sickle cell disease: Systematic review and meta-analysis. | iScience | 2026 | 42657270 | PubTator, text mining | PubMed |
| Genetic Evidence for Unified Airway Disease: Shared Epithelial and Immune Architecture Across Major Airway Diseases. | Int J Mol Sci | 2026 | 42653451 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs and Circular RNAs in the Pathobiology of T-Cell Lymphoma. | Cancers (Basel) | 2026 | 42649850 | PubTator, text mining | PubMed |
| Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice. | Nat Biomed Eng | 2026 | 42557300 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress promotes leukemic plasmacytoid dendritic cell differentiation skewing and immune suppression in acute myeloid leukemia. | Leukemia | 2026 | 42547819 | PubTator, text mining | PubMed |
| The Bcl11-Cxxc1 axis regulates stage-specific chromatin accessibility during lymphocyte development. | Genes Dev | 2026 | 42547288 | PubTator, text mining | PubMed |
| Gene Therapy for β-Haemoglobinopathies: From Molecular Correction to Curative Medicine. | Biomedicines | 2026 | 42511925 | PubTator, text mining | PubMed |
| CRISPRing through time: How cutting-edge technology is revolutionizing life sciences and medicine. | Mol Ther Nucleic Acids | 2026 | 42494498 | PubTator, text mining | PubMed |
| Bcl11a orchestrates multilineage integrity in aging hematopoiesis by regulating multipotent progenitor fate decisions. | Cell Rep | 2026 | 42475180 | PubTator, text mining | PubMed |
| Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer. | Mol Oncol | 2026 | 42462791 | PubTator, text mining | PubMed |
| Non-genotoxic transplantation and in vivo selection through epitope editing. | Nature | 2026 | 42420446 | PubTator, text mining | PubMed |
| Unlocking thalidomide response as a hemoglobin F augmentation agent in transfusion-dependent β-thalassemia: the genetic impact of BCL11A, HBS1L-MYB, and XmnI polymorphism. | Diagn Pathol | 2026 | 42415097 | PubTator, text mining | PubMed |
| Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the HBG1/2 promoters. | Mol Ther Nucleic Acids | 2026 | 42405279 | PubTator, text mining | PubMed |
| Efficacy, Safety, and Treatment-Delivery Feasibility of Autologous Gene Therapy for Sickle Cell Disease: A Systematic Review With Descriptive Synthesis of Clinical Trials. | Eur J Haematol | 2026 | 42400217 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers